2020
DOI: 10.1016/j.ejmech.2020.112663
|View full text |Cite
|
Sign up to set email alerts
|

Semisynthesis of novel magnolol-based Mannich base derivatives that suppress cancer cells via inducing autophagy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
12
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
9

Relationship

3
6

Authors

Journals

citations
Cited by 21 publications
(12 citation statements)
references
References 24 publications
0
12
0
Order By: Relevance
“… Honokiol and magnolol (Figure ), a class of natural biphenolic compounds, are derived from the root bark of the Chinese medicinal plant Magnolia officinalis (“Hou Po” in Chinese). Honokiol and magnolol have many pharmacological effects, including anticancer, antioxidant, neuroprotective, and antimicrobial activities. Recently, honokiol and its analogues ( 3 and 4 , Figure ) were reported to exhibit antibacterial activity against S. aureus or Streptococcus mutans probably via a membrane-associated mechanism, but these analogues are not yet considered ideal lead compounds with potential applications. ,, Based on the abovementioned, and to obtain more potent antibacterial honokiol/magnolol analogues, we designed some analogues that bind cationic AMP fragments to honokiol/magnolol.…”
Section: Introductionmentioning
confidence: 99%
“… Honokiol and magnolol (Figure ), a class of natural biphenolic compounds, are derived from the root bark of the Chinese medicinal plant Magnolia officinalis (“Hou Po” in Chinese). Honokiol and magnolol have many pharmacological effects, including anticancer, antioxidant, neuroprotective, and antimicrobial activities. Recently, honokiol and its analogues ( 3 and 4 , Figure ) were reported to exhibit antibacterial activity against S. aureus or Streptococcus mutans probably via a membrane-associated mechanism, but these analogues are not yet considered ideal lead compounds with potential applications. ,, Based on the abovementioned, and to obtain more potent antibacterial honokiol/magnolol analogues, we designed some analogues that bind cationic AMP fragments to honokiol/magnolol.…”
Section: Introductionmentioning
confidence: 99%
“…Secondly, the nitro group was successfully introduced at the ortho position of hydroxyl groups of the honokiol via nitration reaction to obtain 3,5′-dinitrohonokiol ( 2 ), which was then reduced by SnCl 2 to produce 3,5′-diaminohonokiol ( 3 ). Subsequently, 3,5′-diaminohonokiol ( 3 ) was reacted with urea at 140 °C to obtain another key cyclized product 4 [ 24 ]. Finally, a series of novel honokiol derivatives 6a - p containing various 3-((5-phenyl-1,3,4-oxadiazol-2-yl)methyl)oxazol-2(3 H )-ones were smoothly prepared by reacting compound 4 with the corresponding 2-chloromethyl-5-substituted phenyl-1,3,4-oxadiazoles 5a - p in the presence of K 2 CO 3 and KI [ 25 ].…”
Section: Resultsmentioning
confidence: 99%
“…Compound 4ag displayed IC 50 values of 20.52, 45.01, and 44.45 μM against T47D, MDA-MB-231, and A549 cancer cells, respectively. Of note, the cytotoxic effect of 4ia on MCF-7 and T47D cells was 1.96- and 4.27-fold more potent than that of the positive control of berberine, respectively. Quinoxaline 4ab also displayed 3.94 times stronger cytotoxicity than berberine against T47D cancer cells.…”
Section: Resultsmentioning
confidence: 99%